2005N-0354 Consumer-Directed Promotion of Regulated Medical Products; Part 15 Public Hearing
FDA Comment Number : EC333
Submitter : Ms. Thomas Norton Date & Time: 12/09/2005 11:12:22
Organization : Ms. Thomas Norton
Category : Drug Industry
Issue Areas/Comments
Dear members of the FDA,

Psychiatric medications which are promoted so heavily to consumers via every conceivable form of media are using false and misleading information to create more consumers. We are talking about dangerous, mind-altering drugs; many of which have just received 'Black Box Warnings' for their potential to cause mania and suicide. There is no scientific evidence to support the statement that depression is the result of a 'chemical imbalance.' There are no tests, no scans, and no genetic or biological markers to truly validate any underlying condition. Insinuating that a biological condition exists and that a specific drug 'corrects' the condition is not only false but fraudulent.